Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 38 - Medicinal preparations containing peptides
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
10/1998
10/27/1998US5827703 Methods and composition for in vivo gene therapy
10/27/1998US5827702 Contacting an ocular cell with exogenous nucleic acid under conditions permissive for it uptake and expression; genetic engineering
10/27/1998US5827694 Bovine, porcine, feline, rabbit interferons
10/27/1998US5827693 Expression of recombinant hemoglobin and hemoglobin variants in yeast
10/27/1998US5827692 Parasiticides against heartworm, elephantiasis
10/27/1998US5827691 Process for preparing a protein which inhibits metastasis of cancer
10/27/1998US5827689 Encoding fatty acid biosynthesis (fabd) polypeptides expressed in bacterial genes; vaccines, immunology
10/27/1998US5827688 Secreted proteins and polynucleotides encoding them
10/27/1998US5827686 Method of expressing genes in mammalian cells
10/27/1998US5827683 Nucleic acids encoding BSSL variants
10/27/1998US5827672 Human monocyte elastase inhibitor antibodies
10/27/1998US5827654 Basal body rod protein genes of campylobacter
10/27/1998US5827534 Oral dosage composition comprising zonnula occludens toxin and a therapeutic agent for intestinal delivery
10/27/1998US5827525 Buccal delivery system for therapeutic agents
10/27/1998US5827519 Human herpesvirus type 6 protein p100, the corresponding DNA sequences, their preparation and use
10/27/1998US5827518 Insect immunosuppressants; insecticides
10/27/1998US5827517 CCK antibodies used to improve feed efficiency
10/27/1998US5827516 Decreasing major histocompatibility complex class ii antigen in mammal by introducing into antigen presenting cell an expression vector comprising a nucleic acid molecule coding for expression of peptide which binds to mhc class ii molecule
10/27/1998US5827513 Methods of treating insulin-dependent diabetes mellitus by administration of IL-10
10/27/1998US5827512 Method for the treatment of bronchial asthma and like hypersensitivity diseases by administration of anionic polymers
10/27/1998US5827498 Tumor affinity peptide, and radioactive diagnostic agent and radioactive therapeutic agent containing the peptide
10/27/1998CA2152387C Synergistic anti-viral compositions
10/27/1998CA2063721C Mycobacterium chelonae polar glycopeptidolipids-based immune booster medication
10/27/1998CA2049017C Human-derived glycoprotein, biologically active factor which includes glyoprotein, and pharmaceutical product which comprises biologically active factor as active component
10/27/1998CA1340107C Linear and cyclic analoques of alpha-msh fragments with extraordinary potency
10/27/1998CA1340102C Novel polypeptides with a blood coagulation-inhibiting action, processesfor their preparation and isolation, their use and agents containing them
10/25/1998CA2229449A1 Novel receptor protein and its use
10/24/1998CA2228743A1 Novel integrin ligand itgl-tsp
10/23/1998CA2235457A1 Prevention and treatment of enterohemorrhagic e. coli infection
10/22/1998WO1998046785A1 Dendritic cell hybrids
10/22/1998WO1998046779A1 Adenoviral vectors comprising a modified e4 region but retaining e4orf3
10/22/1998WO1998046771A2 Highly purified mocarhagin, a cobra venom protease, polynucleotides encoding same, related proteases, and therapeutic uses thereof
10/22/1998WO1998046769A1 Composition and method for inducing an immune response against tumour-related antigens
10/22/1998WO1998046767A1 Proteins having lecithin-cholesterol acyltransferase-like activity, their production and use
10/22/1998WO1998046765A1 Methods and compositions for synthesis of long chain polyunsaturated fatty acids
10/22/1998WO1998046764A1 Methods and compositions for synthesis of long chain polyunsaturated fatty acids in plants
10/22/1998WO1998046763A1 Methods and compositions for synthesis of long chain polyunsaturated fatty acids
10/22/1998WO1998046761A1 Recombinant proteins of a pakistani strain of hepatitis e and their use in diagnostic methods and vaccines
10/22/1998WO1998046760A1 A gene delivery vehicle expressing the apoptosis-inducing proteins vp2 and/or apoptin
10/22/1998WO1998046758A1 Human tumor-associated kazal inhibitor
10/22/1998WO1998046757A2 Secreted proteins and polynucleotides encoding them
10/22/1998WO1998046756A1 Secreted protein ssp-1 compositions and therapeutic and diagnostic uses therefor
10/22/1998WO1998046754A1 Human rho protein
10/22/1998WO1998046753A1 Regulator of gene transcription
10/22/1998WO1998046751A1 Osteoprotegerin binding proteins and receptors
10/22/1998WO1998046750A1 flt3 LIGAND CHIMERIC PROTEINS
10/22/1998WO1998046748A1 Therapeutic compositions and diagnostic assays for diseases involving trbp
10/22/1998WO1998046746A1 Extracellular/epidermal growth factor like protein
10/22/1998WO1998046745A1 NOVEL dlg FAMILY MOLECULE, POLYNUCLEOTIDE ENCODING THE SAME, ANTIBODY AGAINST THE SAME, AND METHOD FOR DETECTING dlg GENE
10/22/1998WO1998046743A1 Novel ldl-receptor
10/22/1998WO1998046741A1 Dna fragmentation factor
10/22/1998WO1998046740A1 Method of treating restenosis by antisense targeting of cmv
10/22/1998WO1998046736A1 Novel multidrug resistance-associated polypeptide
10/22/1998WO1998046731A1 Inhibitors for urokinase receptor
10/22/1998WO1998046722A1 Direct expression of peptides into culture media
10/22/1998WO1998046648A1 Interactive system for substance presentation and elimination
10/22/1998WO1998046645A2 Method for the production of antihuman antigen receptors and uses thereof
10/22/1998WO1998046644A1 Novel protein and process for producing the same
10/22/1998WO1998046643A1 TUMOR NECROSIS FACTOR RECEPTOR RELATED PROTEINS TANGO-63d AND TANGO-63e
10/22/1998WO1998046642A1 MODIFIED TNFα MOLECULES, DNA ENCODING SUCH MODIFIED TNFα MOLECULES AND VACCINES COMPRISING SUCH MODIFIED TNFα MOLECULES AND DNA
10/22/1998WO1998046641A1 Novel polypeptides within the growth factor superfamily
10/22/1998WO1998046640A2 Methods and compositions for inducing immunosuppression
10/22/1998WO1998046638A1 A novel th2-specific gene
10/22/1998WO1998046637A2 Herpes simplex virus us3 and icp4 as inhibitors of apoptosis
10/22/1998WO1998046636A2 β-AMYLOID PEPTIDE-BINDING PROTEINS AND POLYNUCLEOTIDES ENCODING THE SAME
10/22/1998WO1998046635A1 GnRH ANTAGONISTS
10/22/1998WO1998046634A1 GnRH ANTAGONISTS BEING MODIFIED IN POSITIONS 5 AND 6
10/22/1998WO1998046633A1 Cytomodulating lipophilic peptides for modulating immune system activity and inhibiting inflammation
10/22/1998WO1998046632A2 Inhibitors for urokinase receptor
10/22/1998WO1998046630A1 Hepatitis c ns3 protease inhibitors
10/22/1998WO1998046628A1 SELECTIVE FACTOR Xa INHIBITORS
10/22/1998WO1998046627A1 SELECTIVE FACTOR Xa INHIBITORS
10/22/1998WO1998046626A1 SELECTIVE FACTOR Xa INHIBITORS
10/22/1998WO1998046625A1 Dipeptide inhibitors of protein farnesyltransferase
10/22/1998WO1998046624A1 A method for stimulating red blood cell production
10/22/1998WO1998046622A1 RECEPTORS FOR TGF-β-RELATED NEUROTROPHIC FACTORS
10/22/1998WO1998046620A1 A novel human g-protein coupled receptor
10/22/1998WO1998046597A1 Serine protease inhibitors
10/22/1998WO1998046581A1 Synergistic method for treating cancer
10/22/1998WO1998046580A1 Deacylation process and product
10/22/1998WO1998046579A1 Teicoplanin derivatives
10/22/1998WO1998046289A1 Biodegradable osteosynthesis implant
10/22/1998WO1998046272A1 Antisense oligonucleotide compositions and methods for the modulation of activating protein 1
10/22/1998WO1998046269A1 Permucous preparation
10/22/1998WO1998046266A1 Compositions containing an angiotensin ii antagonist and an angiotensin ii agonist for use in the treatment of erectile dysfunction
10/22/1998WO1998046265A1 Methods for using antagonistic anti-avb3 integrin antibodies
10/22/1998WO1998046264A1 Antagonistic anti-avb3 integrin antibodies
10/22/1998WO1998046258A2 Use of chondroitinase in the manufacture of a medicament in the treatment and prevention of mucoid secretions
10/22/1998WO1998046257A1 Compositions comprising conjugates of stable, active, human ob protein with antibody fc chain and methods
10/22/1998WO1998046256A1 Treatment of hepatitis b infection with thymosin alpha 1 and famciclovir
10/22/1998WO1998046255A1 Inhibition of b-1 cell mediated immune conditions
10/22/1998WO1998046254A1 Ngf for the prevention of demyelination in the nervous system
10/22/1998WO1998046253A1 Use of cartilage oligomeric matrix protein for the treatment of rheumatoid arthritis
10/22/1998WO1998046252A1 Therapeutic, prophylactic and diagnostic agent for cancer, useful for characterising cancer cells with individual properties
10/22/1998WO1998046251A1 Immunomodulator and pharmaceutical compositions with antitumor properties, and a food additive
10/22/1998WO1998046250A1 Peptide antiestrogen compositions and methods for treating breast cancer
10/22/1998WO1998046249A1 Method of treating gastrointestinal ulcers and compositions therefor
10/22/1998WO1998046248A1 Method and material for inhibiting complement
10/22/1998WO1998046247A1 Solid phase synthesis of immunosuppressive agents
10/22/1998WO1998046246A1 α-O-LINKED GLYCOCONJUGATES WITH CLUSTERED (2,6)-ST EPITOPES, METHODS OF PREPARATION AND USES THEREOF
1 ... 2579 2580 2581 2582 2583 2584 2585 2586 2587 2588 2589 2590 2591 2592 2593 2594 2595 2596 2597 2598 2599 ... 3163